Zhejiang Orient Gene Biotech Co., Ltd (SHA:688298)

China flag China · Delayed Price · Currency is CNY
23.37
+0.44 (1.92%)
Mar 10, 2026, 1:05 PM CST
-22.72%
Market Cap 4.43B
Revenue (ttm) 958.99M
Net Income (ttm) -563.62M
Shares Out 193.20M
EPS (ttm) -2.93
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 804,844
Average Volume 1,867,384
Open 23.07
Previous Close 22.93
Day's Range 23.03 - 23.43
52-Week Range 21.14 - 36.00
Beta 1.16
RSI 37.74
Earnings Date Apr 29, 2026

About SHA:688298

Zhejiang Orient Gene Biotech Co., Ltd researches and develops, produces, and sells in vitro diagnostic products worldwide. Its products include POCT instant diagnostic reagents, used for detection of infectious diseases, drugs of abuse, fertility, tumor marker, and cardiac marker detection. The company offers its products for various categories, including COVID-19 diagnosis solutions; immunological diagnosis; quantum-beads flowcytometry; instrument; dry biochemical strips; raw materials; FISH probes; animal health; biochemistry; molecular diagn... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2005
Employees 2,434
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688298
Full Company Profile

Financial Performance

In 2025, SHA:688298's revenue was 958.99 million, an increase of 15.83% compared to the previous year's 827.92 million. Losses were -563.62 million, 6.54% more than in 2024.

Financial Statements

News

There is no news available yet.